Literature DB >> 15051133

A novel behavioral paradigm for assessing tinnitus using schedule-induced polydipsia avoidance conditioning (SIP-AC).

Edward Lobarinas1, Wei Sun, Ross Cushing, Richard Salvi.   

Abstract

A behavioral technique was developed that allowed the onset and recovery of tinnitus to be measured in individual rats treated with different doses of salicylate. Food-restricted rats were self-trained to lick for water during the time between scheduled delivery of food pellets, i.e., schedule-induced polydipsia (SIP). SIP-induced licking was placed under stimulus control by administering foot shock if licks occurred when sound (one of six stimuli, 40 dB SPL) was present; rats were allowed to lick during quiet. After the number of licks-in-quiet (correct response) exceeded 90% of total licks, rats were treated with saline and four different doses of salicylate (50, 100, 150 and 350 mg/kg, intraperitoneally (i.p.); 2 days). Performance was assessed before, during and after treatment. Licks-in-sound remained extremely low with saline and all four salicylate doses indicating that the sounds were audible under all treatment conditions. Licks-in-quiet remained high during the saline control and 50 mg/kg dose of salicylate, behavior consistent with the absence of tinnitus. However, licks-in-quiet showed a statistically significant decline with the 150 and 350 mg/kg dose, behavior consistent with the presence of tinnitus. Licks-in-quiet gradually recovered to baseline level 2-3 days following high-dose salicylate treatments, behavior consistent with the gradual disappearance of tinnitus. The salicylate dose needed to induce tinnitus and the length of recovery are consistent with previous reports, providing support for the method. The ability to obtain sequential estimates of tinnitus-like behavior in an animal after administering a tinnitus-inducing agent could aid in understanding the underlying neural mechanisms and assessing potential treatments.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15051133     DOI: 10.1016/S0378-5955(04)00019-X

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  61 in total

1.  The gap-startle paradigm for tinnitus screening in animal models: limitations and optimization.

Authors:  Edward Lobarinas; Sarah H Hayes; Brian L Allman
Journal:  Hear Res       Date:  2012-06-21       Impact factor: 3.208

2.  Comparison of salicylate- and quinine-induced tinnitus in rats: development, time course, and evaluation of audiologic correlates.

Authors:  Massimo Ralli; Edward Lobarinas; Anna Rita Fetoni; Daniel Stolzberg; Gaetano Paludetti; Richard Salvi
Journal:  Otol Neurotol       Date:  2010-07       Impact factor: 2.311

Review 3.  Animal Models of Tinnitus: A Review.

Authors:  Alexander Galazyuk; Thomas J Brozoski
Journal:  Otolaryngol Clin North Am       Date:  2020-04-21       Impact factor: 3.346

4.  Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model.

Authors:  Thomas J Brozoski; T Joseph D Spires; Carol A Bauer
Journal:  J Assoc Res Otolaryngol       Date:  2007-01-13

5.  Tinnitus Correlates with Downregulation of Cortical Glutamate Decarboxylase 65 Expression But Not Auditory Cortical Map Reorganization.

Authors:  Asako Miyakawa; Weihua Wang; Sung-Jin Cho; Delia Li; Sungchil Yang; Shaowen Bao
Journal:  J Neurosci       Date:  2019-11-08       Impact factor: 6.167

6.  Effects of sodium salicylate on spontaneous and evoked spike rate in the dorsal cochlear nucleus.

Authors:  Lei Wei; Dalian Ding; Wei Sun; Matthew A Xu-Friedman; Richard Salvi
Journal:  Hear Res       Date:  2010-04-27       Impact factor: 3.208

7.  Time course of tinnitus development following noise exposure in mice.

Authors:  Jeremy Turner; Deb Larsen; Larry Hughes; Diederik Moechars; Susan Shore
Journal:  J Neurosci Res       Date:  2012-03-21       Impact factor: 4.164

8.  Does tinnitus "fill in" the silent gaps?

Authors:  Jennifer Campolo; Edward Lobarinas; Richard Salvi
Journal:  Noise Health       Date:  2013 Nov-Dec       Impact factor: 0.867

Review 9.  Emerging pharmacotherapy of tinnitus.

Authors:  Berthold Langguth; Richard Salvi; Ana Belén Elgoyhen
Journal:  Expert Opin Emerg Drugs       Date:  2009-12       Impact factor: 4.191

Review 10.  Salicylate-induced cochlear impairments, cortical hyperactivity and re-tuning, and tinnitus.

Authors:  Guang-Di Chen; Daniel Stolzberg; Edward Lobarinas; Wei Sun; Dalian Ding; Richard Salvi
Journal:  Hear Res       Date:  2012-11-27       Impact factor: 3.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.